Pharma Bio’s Managing Director Y.V. Deigin presenting the company to foreign delegations at Skolkovo’s Hypercube

Our mission in stages:

  • Develop novel medications for a variety of important diseases.
  • Create a scientific and industrial base in Russia for the research and development of innovative biotechnology.
  • Organize local production of original medications based on synthetic peptides.
  • Help Russia reclaim scientific leadership in the field of medical biotechnology.
  • Improve patients’ quality of life through  prevention and treatment of socially significant diseases.

Innovative mission - we aim to develop and introduce into wide medical practice novel original peptide drugs:

Инновационная цель – В результате реализации проекта мы рассчитываем разработать и внедрить в производство и медицинскую практику новые оригинальные пептидные лекарственные средства:

  • a drug for the prevention and treatment of Alzheimer’s disease;
  • a hematopoietic stimulant, which restores homeostasis after chemotherapy and radiation therapy;
  • a stress-protector, a drug for the treatment and prevention of anxiety disorders;
  • an anti-alcoholism drug;
  • a drug for the treatment of autoimmune diseases: psoriasis, atopic dermatitis, rheumatoid arthritis, etc.

Economic mission – There is virtually no domestic industrial production of peptide API in Russia, which creates a substantial dependency on imported API for the Russian pharmaceutical industry. We are striving to create a domestic production of API and peptide drugs corresponding to international standards of quality and in line with peptide industry trends.

Social mission – We are aiming to improve access to the most modern international standards of drug therapy for people afflicted by socially significant diseases. The prevalence of diseases we are focusing on reaches up to 20% of total population. Our research activities focus on the development and introduction into clinical practice of novel original drugs to treat a wide range of diseases. Our goal is to improve the quality of life of patients and to increase life expectancy.

International mission – We intend to actively pursue mutually beneficial international partnerships in the rapidly developing field of peptide biotechnology. This is meant not only as a risk-sharing undertaking, but also a means of expanding the market for our products, as well as a way of strengthening Russia’s position in this high-tech field.